Effects of SLCO1B1 polymorphism on the pharmacokinetics of the oral antidiabetic drugs repaglinide, nateglinide, rosiglitazone, and pioglitazone
Effects of SLCO1B1 polymorphism on the pharmacokinetics of the oral antidiabetic drugs repaglinide, nateglinide, rosiglitazone, and pioglitazone
Tallennettuna:
Ulkoasu |
80 sivua + original publications |
---|---|
Julkaisija |
Helsinki :
University of Helsinki,
2008.
|
Opinnäyte | Academic dissertation : University of Helsinki |
Luokitus | |
Aiheet | |
Lisätiedot | Annikka Kalliokoski |
ISBN |
978-952-92-4630-4 sidottu |